← All stocks

CHEMED CORP

CHE No buying or selling

CIK 0000019584 #1119 in the set updated 21 Sep 2026

Bought (1 mo)

$0.00

out of their own pocket, the only kind of buying there is

Sold (1 mo)

$0.00

$0.00 on a plan · $0.00 straight out of an exercise

Sold at will

$0.00

0 of 0 sales

Net

$0.00

$0.00 against sales at will

By person

14 insiders · 0 transactions

Insider

Role

Bought

Sold

Net

Holding

Worth

Change

MCNAMARA KEVIN J

president and CEO

—

70,418

$38.11M

−34.6%

HUTTON THOMAS C

vice president

—

32,481

$17.58M

+1.2%

LEE SPENCER S

executive vice president

—

13,912

$7.53M

−30.5%

Witzeman Michael D

VP & Chief Financial Officer

—

5,953

$3.22M

+57.3%

LINDELL ANDREA R

Director

—

4,578

$2.48M

−20.0%

GRACE PATRICK P

Director

—

3,533

$1.91M

+8.0%

Judkins Brian C

VP and Chief Legal Officer

—

3,344

$1.81M

+118.1%

WALSH GEORGE J III

Director

—

3,209

$1.74M

−1.1%

Heaney Christopher J

Director

—

2,775

$1.50M

+31.4%

DeLyons Ron

Director

—

2,052

$1.11M

+47.7%

Mount John Meredith Jr.

Director

—

1,316

$712.17K

+101.5%

McCarthy Eileen P

Director

—

1,241

$671.58K

+114.7%

Wherley Joel L

CEO - Vitas Healthcare

—

1,181

$639.11K

+79.2%

Westfall Nicholas Michael

Executive Vice President

—

$0.00

−100.0%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.

Individual transactions

Nothing of that kind in this period.

What was left out

Form 4 filings counted 2

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 0

Sales straight out of an exercise 0

Sales at will 0

Transactions with no price 0

Shares from compensation/vesting 0

History held since 23 Sep 2016